| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenoid cystic carcinoma of the lung: Interest of 18FDG PET/CT in the management of an atypical presentation
|
Campistron, Marion
|
|
2008
|
59 |
1 |
p. 133-136
4 p.
|
artikel
|
| 2 |
A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
|
Bae, Sung Hwa
|
|
2008
|
59 |
1 |
p. 76-80
5 p.
|
artikel
|
| 3 |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Ho, Chao-Chi
|
|
2008
|
59 |
1 |
p. 105-110
6 p.
|
artikel
|
| 4 |
Contents
|
|
|
2008
|
59 |
1 |
p. vii-viii
nvt p.
|
artikel
|
| 5 |
Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer
|
Suzuki, Hiromitsu
|
|
2008
|
59 |
1 |
p. 24-31
8 p.
|
artikel
|
| 6 |
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
|
Georgoulias, Vassilis
|
|
2008
|
59 |
1 |
p. 57-63
7 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2008
|
59 |
1 |
p. v-
1 p.
|
artikel
|
| 8 |
Effect of surgical volume and hospital type on outcome in non-small cell lung cancer surgery: A Finnish population-based study
|
Sioris, Thanos
|
|
2008
|
59 |
1 |
p. 119-125
7 p.
|
artikel
|
| 9 |
Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
|
Rajeswaran, Anand
|
|
2008
|
59 |
1 |
p. 1-11
11 p.
|
artikel
|
| 10 |
Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib
|
Fujiwara, Yoshiro
|
|
2008
|
59 |
1 |
p. 81-87
7 p.
|
artikel
|
| 11 |
Ensuring the right PET scan for the right patient
|
Spiro, Stephen G.
|
|
2008
|
59 |
1 |
p. 48-56
9 p.
|
artikel
|
| 12 |
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer
|
Lee, Hyun Woo
|
|
2008
|
59 |
1 |
p. 95-104
10 p.
|
artikel
|
| 13 |
Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
|
Han, Ji-Youn
|
|
2008
|
59 |
1 |
p. 69-75
7 p.
|
artikel
|
| 14 |
Instruction to Authors
|
|
|
2008
|
59 |
1 |
p. 142-145
4 p.
|
artikel
|
| 15 |
KL-6 and poor prognosis in NSCLC patients treated with gefitinib
|
Ohara, Gen
|
|
2008
|
59 |
1 |
p. 138-
1 p.
|
artikel
|
| 16 |
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
|
Esendagli, G.
|
|
2008
|
59 |
1 |
p. 32-40
9 p.
|
artikel
|
| 17 |
Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung
|
Kim, Young Tae
|
|
2008
|
59 |
1 |
p. 111-118
8 p.
|
artikel
|
| 18 |
Multimodal treatment of thymic carcinoma: Report of nine cases
|
Magois, Eline
|
|
2008
|
59 |
1 |
p. 126-132
7 p.
|
artikel
|
| 19 |
Oestrogen receptor β over expression in males with non-small cell lung cancer is associated with better survival
|
Skov, Birgit Guldhammer
|
|
2008
|
59 |
1 |
p. 88-94
7 p.
|
artikel
|
| 20 |
Outcomes of unselected routinely treated lung cancer patients
|
Debevec, Lučka
|
|
2008
|
59 |
1 |
p. 140-141
2 p.
|
artikel
|
| 21 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy
|
Chou, Kun-ta
|
|
2008
|
59 |
1 |
p. 64-68
5 p.
|
artikel
|
| 22 |
Prognostic markers for stage I non-small cell lung cancer
|
Ohara, Gen
|
|
2008
|
59 |
1 |
p. 137-
1 p.
|
artikel
|
| 23 |
Re:“KL-6 and poor prognosis in NSCLC patients treated with gefitinib”
|
Fujiwara, Yoshiro
|
|
2008
|
59 |
1 |
p. 139-
1 p.
|
artikel
|
| 24 |
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells
|
von Haussen, Judith
|
|
2008
|
59 |
1 |
p. 12-23
12 p.
|
artikel
|
| 25 |
VEGF121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small cell lung carcinoma patients
|
Kawai, Hideki
|
|
2008
|
59 |
1 |
p. 41-47
7 p.
|
artikel
|
Tijdschrift beschrijving